A61P 17/06
Antipsoriatics
A61P17/06 (Antipsoriatics) appears on 14,271 US grants and 21,736 published applications in this corpus.
Search patents in A61P- Granted patents
- 14,271
- Published applications
- 21,736
- Assignees
- 4,755
- Inventors
- 30,230
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 12 | 0 |
| 1995 | 13 | 0 |
| 1996 | 26 | 0 |
| 1997 | 47 | 0 |
| 1998 | 67 | 0 |
| 1999 | 109 | 0 |
| 2000 | 137 | 0 |
| 2001 | 252 | 63 |
| 2002 | 314 | 452 |
| 2003 | 320 | 806 |
| 2004 | 304 | 1035 |
| 2005 | 320 | 1055 |
| 2006 | 437 | 1043 |
| 2007 | 467 | 1050 |
| 2008 | 522 | 1250 |
| 2009 | 601 | 1361 |
| 2010 | 846 | 1600 |
| 2011 | 857 | 1512 |
| 2012 | 1003 | 1384 |
| 2013 | 1114 | 1060 |
| 2014 | 1007 | 1192 |
| 2015 | 860 | 968 |
| 2016 | 713 | 905 |
| 2017 | 724 | 877 |
| 2018 | 622 | 803 |
| 2019 | 628 | 730 |
| 2020 | 527 | 578 |
| 2021 | 386 | 483 |
| 2022 | 317 | 441 |
| 2023 | 226 | 359 |
| 2024 | 204 | 309 |
| 2025 | 181 | 250 |
| 2026 | 102 | 170 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Bertholletia excelsa extract and use thereof29 Sep 2026US 12,746,195 B2Clariant Brasil LTDA.
- Traditional Chinese medicine composition for treating psoriasis, preparation method therefor and use thereof22 Sep 2026US 12,741,000 B2Tasly Pharmaceutical Group Co., Ltd.
- Glutarimide compound and use thereof22 Sep 2026US 12,741,031 B2Medshine Discovery Inc.
- Formulation to deliver lipophilic active ingredients8 Sep 2026US 12,728,099 B2Performs S.R.L.
- Immunomodulator8 Sep 2026US 12,729,195 B2Hitgen Inc.
- Method of inhibiting adenosine triphosphate secretion, method of inhibiting hepatic stellate cell activation, method of deactivating hepatic stellate cell, method of treating hepatic fibrosis, method of treating non-alcoholic steatohepatitis, and method of treating psoriasis8 Oct 2026US 2026/0306500 A1Kurume University
- Methods of treating inflammatory diseases8 Oct 2026US 2026/0308246 A1Boehringer Ingelheim International GmbH
- Anti-human interleukin 23 monoclonal antibody and application thereof8 Oct 2026US 2026/0308249 A1Qyuns Therapeutics Co., Ltd.
- Anti-human interleukin 23 monoclonal antibody and application thereof8 Oct 2026US 2026/0308250 A1Qyuns Therapeutics Co., Ltd.
- Treating psoriasis using a small molecule inhibitor of tumor necrosis factor alpha1 Oct 2026US 2026/0294906 A1Sanofi
Most cited
By later US patents
- (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses1,031US 7,094,916 B2Wisconsin Alumni Research Foundation · 2006
- Regulation of endogenous gene expression in cells using zinc finger proteins648US 6,534,261 B1Sangamo BioSciences, Inc. · 2003
- Immunostimulatory nucleic acid molecules472US 6,207,646 B1Coley Pharmaceutical Group, Inc. · 2001
- Modified antibody variable domains462US 5,766,886 AXoma Corporation · 1998
- Immunostimulatory nucleic acid molecules461US 6,239,116 B1Coley Pharmaceutical Group, Inc. · 2001